International reference: 2 US FDA recalls for this ingredient

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile. (vasopressin)

Sub-potent drug: failure to maintain potency through the duration of the labeled expiration/beyond-use date. (vasopressin)

US-market enforcement records (OpenFDA), shown for reference - not specific to this product in South Africa.

Registered South Africa · SAHPRA

VASOPRESSIN 40 units/100 ml CIPLA

Vasopressin

57/7.2/402.400

What it does

Vasopressin is a hormone used to help control water balance in the body and manage certain medical conditions.

Commonly used for: diabetes insipidus, low blood pressure (hypotension)

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
57/7.2/402.400
Registration date
2025/04/08
Expiry date
-
Status
Registered
Active ingredient
Vasopressin
Dosage form
-
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
-
Applicant / LTR
Cipla Medpro (Pty) Ltd
Country of origin
-

Source: South African Health Products Regulatory Authority · fetched 2026-04-15 21:29:40 · updated 2026-10-21 04:02:22

Drug Interactions

3
Check interactions

Unknown (3)

Vasopressin - decreases antidiuretic effect

Alcoholmightdecreasetheantidiureticeffectofvasopressin. oTheoretical Aldesleukin →seeTABLE15p.1520(myelosuppression) Alectinib →seeTABLE6p.1518(bradycardia),TABLE1p.1517 (hepatotoxicity) com/codemedic

Unknown Theoretical

Vasopressin - decreases antidiuretic effect

Heparin might decrease the antidiuretic effect of vasopressin. Theoretical Hepatitis B immunoglobulin → see immunoglobulins Herpes-zoster vaccine, live → see live vaccines HIV-protease inhibitors . .

Unknown Theoretical

Vasopressin - increases hypertensive effect

Sympathomimetics, vasoconstrictor (adrenaline/epinephrine) might increase the hypertensive effect of vasopressin.

Unknown Theoretical

Data from BNF 85 (British National Formulary). This is not a substitute for professional medical advice. Matched via: exact

Disclaimer: This information is sourced from South African Health Products Regulatory Authority (South Africa). Always consult a qualified healthcare professional before using any medication.

About this medicine

Vasopressin is a hormone used to help control water balance in the body and manage certain medical conditions.

What it treats

  • diabetes insipidus
  • low blood pressure (hypotension)

How it works

Vasopressin helps the kidneys retain water, which can increase blood volume and pressure.

Who it's for

It is prescribed for people with diabetes insipidus or severe low blood pressure.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: Vasopressin

BNF-referenced

Vasopressin, also known as antidiuretic hormone (ADH), is an endogenous peptide hormone produced in the hypothalamus and released by the posterior pituitary gland. It plays a critical role in regulating water balance in the body by promoting water reabsorption in the kidneys, thereby concentrating urine and reducing urine volume. Vasopressin also has vasoconstrictive properties, which can influence blood pressure and blood volume.

Indications

  • Diabetes insipidus (central)
  • Control of esophageal variceal bleeding
  • Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
  • Adjunct in acute massive hemorrhage of gastrointestinal tract or esophageal varices (specialist use only)

Dosage

Adults: For diabetes insipidus, the initial dose is 5-10 units intramuscularly

Mechanism of action

Vasopressin exerts its effects primarily through binding to vasopressin receptors, specifically V1 and V2 receptors. The V1 receptors are located on vascular smooth muscle cells and mediate vasoconstriction, while V2 receptors are found in the renal collecting ducts and promote water reabsorption by stimulating aquaporin-2 channels' translocation to the apical membrane of collecting duct cells. This mechanism enhances water permeability, leading to increased water reabsorption and decreased urine output.

Pharmacodynamics

The pharmacodynamic effects of vasopressin include increased water reabsorption in the kidneys, leading to concentrated urine and reduced urine output. Additionally, vasopressin causes vasoconstriction, which can increase systemic vascular resistance and, consequently, blood pressure. The hormone's antidiuretic effects are dose-dependent, and its vasoconstrictive effects can also be used therapeutically in specific clinical scenarios such as managing acute variceal bleeding.

Pharmacokinetics

Vasopressin is typically administered via intramuscular, subcutaneous, or intravenous routes. The onset of action varies depending on the route of administration; intravenous administration provides rapid effects. The half-life of vasopressin is approximately 10-20 minutes, and it is metabolized primarily by peptidases in the liver and kidneys. Its clearance can be affected by renal function and the presence of certain drugs that interact with its metabolism.

Contra-indications

  • Chronic nephritis
  • Cardiovascular disease
  • Severe renal impairment
  • Hypersensitivity to vasopressin or any of its components

Adverse effects

  • Hyponatremia
  • Headache
  • Nausea
  • Abdominal cramps
  • Water retention
  • Gastrointestinal upset
  • Hypotension
  • Tachycardia

Interactions

  • CYP3A4 inhibitors (e.g., ketoconazole, erythromycin) may increase vasopressin levels
  • Alcohol may decrease the antidiuretic effect of vasopressin
  • Heparin may decrease the antidiuretic effect of vasopressin
  • Sympathomimetics and vasoconstrictors may increase hypertensive effects

Precautions

  • Use with caution in patients with a history of seizures
  • Monitor fluid balance and electrolytes
  • Assess for signs of water retention and hyponatremia
  • Adjust dosage based on clinical response and tolerability

Pregnancy

Vasopressin may have an oxytocic effect in the third trimester; use with caution.

Breast-feeding

Not known to be harmful during breastfeeding; use caution.

Storage

Store at room temperature, away from light. Do not freeze. Protect from moisture.

Formulations

  • Vasopressin injection (various concentrations)
  • Desmopressin acetate oral lyophilisates
  • Terlipressin acetate injection
BNF 85 (British National Formulary) p.753 BNF for Children 2019-2020 p.91 PubChem / pathway

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.